Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Pharmacological risks : Even if the product is genuine, the adverse effect profile of retatrutide as observed in the published phase 2 clinical trial includes nausea, vomiting, diarrhoea, decreased appetite, and injection-site reactions
Affix your signature and that of a guardian if necessary, to indicate consent
doi: 10.5009/gnl18490
Composition BPC-157: 20 mg Appearance: Lyophilized powder in a sealed research vial Research Focus (non-clinical) Peptide identity and purity assessment Assay development and calibration for quantitative analysis Chromatographic method optimization for impurity profiling Stability characterization of a lyophilized peptide under laboratory storage conditions Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
Airborne Microbes: Dust particles and microorganisms present in the air can settle on exposed surfaces or enter open vials
US$ 21.21
US$ 24.53
US$ 25.47
